<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://psiconautica.org/noticias/ketamina-depresion-ensayo-karma-dep-2-jama-psychiatry/</loc>
    <news:news>
      <news:publication><news:name>Psiconáutica</news:name><news:language>es</news:language></news:publication>
      <news:publication_date>2026-07-16T13:45:29+02:00</news:publication_date>
      <news:title>Un ensayo riguroso cuestiona la eficacia de la ketamina en depresión</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://psiconautica.org/noticias/dmt-depresion-resistente-ensayo-clinico-imperial-2026/</loc>
    <news:news>
      <news:publication><news:name>Psiconáutica</news:name><news:language>es</news:language></news:publication>
      <news:publication_date>2026-07-16T13:05:29+02:00</news:publication_date>
      <news:title>Una sola dosis de DMT reduce la depresión resistente, según ensayo</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://psiconautica.org/noticias/lsd-microdosis-tdah-revision-2026/</loc>
    <news:news>
      <news:publication><news:name>Psiconáutica</news:name><news:language>es</news:language></news:publication>
      <news:publication_date>2026-07-16T12:25:29+02:00</news:publication_date>
      <news:title>La microdosis de LSD no supera al placebo en el TDAH, según revisión</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://psiconautica.org/noticias/fda-guia-ensayos-psicodelicos-psilocibina-2026/</loc>
    <news:news>
      <news:publication><news:name>Psiconáutica</news:name><news:language>es</news:language></news:publication>
      <news:publication_date>2026-07-16T11:45:29+02:00</news:publication_date>
      <news:title>La FDA ultima su guía sobre psicodélicos y acelera la psilocibina</news:title>
    </news:news>
  </url>
</urlset>